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ABSTRACT
Early degenerative changes of articular cartilage are not diagnosed
sensitively enough with conventional X-ray and magnetic resonance
imaging (MRI) techniques. Contrast agent enhanced MRI and com-
puted tomography (CT) have also been applied for imaging degen-
erative changes in cartilage. Contrast enhanced CT (CECT) can be
considered as an analogous X-ray technique to delayed gadolinium-
enhanced MRI of cartilage (dGEMRIC). Both techniques are based on
imaging the diffusion of anionic contrast agent in the cartilage ma-
trix. In this thesis, the diagnostic potential of CECT was investigated
in three in vitro studies and one in vivo study.
In study I, diffusion coefficients of four CT and MRI contrast
agents in cartilage were determined by analyzing CECT measure-
ments using the finite element method (FEM). In addition, diffusion
through the articular surface was compared with diffusion through
the deep cartilage. Study II evaluated the ability of CECT to dis-
tinguish spontaneously healed osteochondral lesions from intact
equine cartilage. In study III, the effects of increase of cross-linking
of collagen on diffusion of anionic and non-ionic contrast agents
were investigated using CECT. In study IV, dGEMRIC and delayed
quantitative CT arthrography (dQCTA i.e. CECT in vivo) were com-
pared with each other and to arthroscopic findings in a clinical
study.
Diffusion coefficients for four contrast agents (ioxaglate, gadopen-
tetate, iodide, gadodiamide) could be determined in study I. Dif-
fusion through superficial cartilage was faster than through deep
cartilage. This appeared to reflect the differences in composition
along cartilage depth: higher water content and lower glycosamino-
glycan concentration in superficial than in deep cartilage. In study II,
CECT was able to distinguish in a quantitative manner the sponta-
neously healed cartilage and subchondral bone from adjacent intact
tissues. In study III, cross-linking induced changes in cartilage fixed
charge density had greater effect on diffusion of anionic contrast
agent as compared to the changes in the steric hindrance. In study
IV, the results of dQCTA normalized with the contrast agent concen-
tration in synovial fluid showed the best agreement with dGEMRIC
at 45 minutes after contrast agent injection. However, neither of
the techniques correlated with the arthroscopic evaluation. Since
normalization with the contrast agent concentration in synovial fluid
was important, it was postulated to be taken into account in future
clinical application of dQCTA.
To conclude, imaging the diffusion dynamics of the contrast
agent in articular cartilage was found to provide valuable informa-
tion about the integrity and composition of cartilage matrix. Fur-
thermore, CECT provided quantitative information on subchondral
bone microstructure and density. Based on the in vivo experiment, it
seems that dQCTA is a potentially useful method in the quantitative
diagnostic imaging of articular cartilage.
National Library of Medicine Classification: QT 36, WE 300, WE 348,
WN 160, WN 206
PACS Classification: 87.19.xn, 87.57.-s, 87.57.Q-, 87.85.Pq
Medical Subject Headings: Cartilage, Articular; Collagen; Contrast Media;
Diagnostic Imaging; Diffusion; Finite Element Analysis; Osteoarthritis;
Tomography, X-Ray Computed
Yleinen suomalainen asiasanasto: diffuusio; kollageenit; kuvantaminen;
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1 Introduction
Articular cartilage is a specialized connective tissue covering the
ends of the articulating bones, e.g. in the knee joint. Normal articular
cartilage is a bluish white, hydrated soft tissue with a unique com-
position and mechanical properties that enable it to withstand high
loads and provide almost frictionless motion in the joint [117, 121].
Cartilage and the menisci contribute to the distribution of loads in
the knee joint, and thus protect the articulating bones from dam-
age [31].
The main components of cartilage are water and two structural
macromolecules, collagen and proteoglycans (PGs). The highly
organized collagen network and the negatively charged PGs form
a porous solid matrix which is filled with interstitial water. The
interactions between the solid matrix and water represent the basis
of the biomechanical behaviour of cartilage under loading [117].
Any disturbances in the main components affect the interactions
between them, and thus the function of cartilage is impaired. The
impairment of the joint due to the presence of degenerative changes
in cartilage and subchondral bone is called osteoarthritis (OA), or
alternatively osteoarthrosis or degenerative joint disease [25, 31].
OA is the most common joint disease, which causes joint pain
and limited mobility [31]. The probability of having knee OA in-
creases with age and is more common in women. Since OA often
leads to total joint replacement and disability to work, the yearly
costs for society are high [68].
The earliest osteoarthritic changes occurring in cartilage are
disruption of the superficial collagen network, a decrease of PG con-
centration and an increase in the water content [31, 111]. Changes in
bone include thickening of the subchondral plate, increased density
of the trabecular bone underneath the subchondral plate and the
formation of cysts and osteophytes [31]. Unfortunately, the early
signs of OA are not visible in plain radiography which still is a
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common way to diagnose OA [35]. Magnetic resonance imaging
(MRI) provides the possibility to image soft tissue, in contrast to
native X-ray techniques, but is more expensive and not available for
all patients. Furthermore, the resolution of MRI is not high enough
to allow the detection of the incipient osteoarthritic changes or minor
cartilage injuries.
During the past years, the application of contrast agents with
MRI and computed tomography (CT) has shown potential in imag-
ing compositional changes of articular cartilage. Delayed gadolinium-
enhanced MRI of cartilage (dGEMRIC) was introduced in the mid
1990s [16–18]. This method is based on the assumption that nega-
tively charged contrast agents will distribute within cartilage in an
inverse relation to the negative fixed charged density (FCD) asso-
ciated with the glycosaminoglycans (GAGs) of PGs. Since the PG
concentration is lower in degenerated cartilage, more contrast agent
is believed to diffuse into osteoarthritic tissue.
An analogous X-ray technique to dGEMRIC, contrast enhanced
CT (CECT), was introduced in 2006 [37, 135]. Many in vitro studies
have revealed its potential to assess the state of cartilage [9, 13, 79,
139, 163, 209]. However, diffusion and distribution of contrast agent
in cartilage are complex phenomena which are also affected by other
constituents in addition to PGs. The collagen concentration and
integrity of the collagen network, water content in cartilage, charge
and molecular weight of the diffusing molecule all contribute to dif-
fusion [79,88,104,107,108,137,180,200,201]. Therefore, the specificity
of both dGEMRIC and CECT as ways to measure the PG content has
been questioned [66, 152, 164, 171]. CECT has recently been tested in
vivo [86], but several questions remain open concerning the optimal
amount of contrast agent and the optimal imaging time points in
relation to contrast agent injection. CECT is referred to as delayed
quantitative CT arthrography (dQCTA) when it is used in in vivo
settings.
In addition to early detection of OA, new sensitive imaging tech-
niques of cartilage are needed for the development of medical and
surgical treatments [20, 26, 141]. This thesis focuses on the further
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development of contrast enhanced CT of cartilage, and consists of
three in vitro studies and one in vivo study. Study I examined the
tissue-averaged axial diffusion coefficients of four different CT and
MRI contrast agents in cartilage. The ability of CECT to distinguish
spontaneously healed osteochondral lesions from adjacent normal
cartilage tissue was investigated in study II. Study III aimed to de-
termine the individual contribution of increased FCD and steric
hindrance of artificially aged, cross-linked collagen network in the
partition of contrast agents. Study IV was an in vivo study investigat-
ing the performance of dGEMRIC and dQCTA and their association
to arthroscopic findings of cartilage status.
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2 Articular cartilage
Articular cartilage (hyaline cartilage) is a specialized connective
tissue located at the ends of the articulating bones. The mean
cartilage thickness in a human knee joint is 2–4 mm depending on
the anatomical location [8, 64]. In a knee joint, cartilage efficiently
distributes loads together with menisci minimizing the stresses
on the bones [29, 117]. Smooth cartilage surfaces provide almost
frictionless motion in the joints together with the lubricating synovial
fluid. Cartilage tissue is characterized as a biphasic material with
fluid and solid phases [117]. The main constituents of the solid phase
are collagen fibers and PGs. The fluid phase consists of interstitial
water and electrolytes. The fluid and solid phases together form
the extracellular matrix (ECM) which surrounds the cartilage cells,
chondrocytes.
2.1 STRUCTURE AND COMPOSITION
Water accounts for approximately 60–80% of the wet weight of
articular cartilage [122, 193]. Some of this water is bound to collagen
fibrils but most of it can move freely in and out of the tissue. The
flow of water greatly affects the mechanical properties of the tissue.
Water is also responsible for the transport of nutrients and ions.
Since cartilage is avascular, the transport occurs through diffusion
and convection from the synovial fluid. Tissue water contains a
high concentration of cations to balance the negative FCD caused by
PGs [29]. The water content decreases from the superficial cartilage
towards the cartilage–bone interface [157, 193].
Collagen accounts for about 10–20% of the wet weight of the
cartilage [122] with type II collagen representing more than 90% of
the total collagen [33]. Collagen fibers form a network which has
a unique, arcade-like organization [21]. Zonal differences in fiber
arrangement and the extensive cross-linking of collagen confer the
Dissertations in Forestry and Natural Sciences No 110 5
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Figure 2.1: Schematic illustration of the structure of articular cartilage (on the left) and
proteoglycan aggregate (on the right). In the superficial zone (5–10% of cartilage thickness),
the collagen fibers are oriented parallel to the surface. In the middle zone (5–20%), the fibers
bend so that they start to become perpendicular to the surface. In the deep zone (70–90%),
the fibers are oriented in a perpendicular manner to the surface and are anchored to the
subchondral bone through the calcified matrix. PG monomers are bound from one end to a
hyaluronic acid chain to form an aggregate. A monomer is composed of a protein core with
GAG chains attached to it.
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tensile and shear stiffnesses and strengths on the tissue [50, 81, 117,
120, 122, 211]. Cartilage is organized into three zones according to
the preferential direction of the fibers [21, 72]. In the superficial
tangential zone (5–10% of cartilage thickness [6]), the fibers are
oriented in parallel to the surface and are densely packed. In the
middle zone (5–20% [6]), the fibers bend so that they start to become
perpendicular to the surface. In the deep zone (70–90% [6]), the
fibers are oriented in a perpendicular manner to the surface and are
anchored to the bone through the calcified cartilage (Figure 2.1).
Collagen fibers are extensively cross-linked which is necessary
for the high tensile strength of the healthy collagen network [11, 50].
Some of the cross-links are formed through non-enzymatic glycation
(NEG) which is a typical phenomenon in natural ageing. NEG is
a reaction between reducing sugars and proteins which produce
advanced glycation endproducts (AGEs). AGEs accumulate in all
proteins, but they are especially prevalent in collagen due to its slow
turnover rate [195]. Cartilage tissue can be artificially aged in vitro
by creating cross-links via sugar-induced NEG. Threose (sugar) has
been used to increase collagen cross-linking in vitro and this has
resulted in an increase of the stiffness of the collagen network [194].
PGs account for 5–10% of the wet weight of the cartilage [117]. A
PG monomer is composed of a protein core with chains of GAG, such
as chondroitin sulphate and keratan sulphate, covalently attached to
it [122]. PG monomers are bound from one end to hyaluronic acid
chains to form large aggregates (Figure 2.1) [33, 119]. Negatively
charged GAGs create a fixed negative charge within the cartilage
matrix [109], and thus attract cations and water into the cartilage.
This together with the repulsive forces between the GAG chains gives
rise to the osmotic swelling pressure which contributes primarily to
the compressive stiffness of cartilage [121, 122]. Swelling pressure,
which generates a prestress in the collagen network, contributes
also to the shear stiffness of cartilage [211]. In humans, the PG
concentration increases from the superficial cartilage to the deep
zone [124, 193].
Chondrocytes are specialized cells; their main function is to
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produce and maintain the ECM of cartilage. The cells account
for only about 1% of the volume of the human cartilage [29, 70,
71]. The chondrocytes are more active in young than in mature
individuals. The activity of chondrocytes to synthesize collagen
and PG in order to replace the degraded matrix components is
influenced by their mechanical and physicochemical environment
[29, 70, 123]. Nevertheless, the chondrocytes have a limited capacity
to maintain the cartilage, especially after mechanical injury. The
causes behind the decline in chondrocytic metabolic response are
not fully understood [29, 121].
2.2 FUNCTIONAL PROPERTIES
PGs are immobilized and entrapped within the fine network of
the collagen fibers. Since the GAG chains are very close to each
other, the repulsive forces between them cause the ECM to swell
(the chemical expansion effect). In addition, the FCD created by
negatively charged GAGs causes the cation concentration inside
the tissue to rise, leading to an osmotic pressure difference and
swelling of the tissue (Donnan osmotic pressure effect). The collagen
network is prestressed by the swelling, and it resists the deformation
of the matrix. Thus, the swelling behaviour and the anisotropic
viscoelastic collagen network can explain how cartilage responds to
loading. [96, 110, 117, 205]
A viscoelastic material responds to loading in a time-dependent
manner [117]. When the cartilage is under the compressive load, the
low permeability helps the tissue to resist the fluid flow within and
out of the tissue. Therefore, the pressurized fluid can support as
much as 95% of the applied load [7, 118, 133]. At the same time, the
collagen tension resists the tissue deformation in a strain-dependent
manner [81, 115, 149]. Thus, collagens and pressurized fluid mainly
support the load in dynamic compression. Under a constant load,
the fluid flows slowly through the porous tissue and this governs the
transient response of cartilage. At equilibrium (static loading), PGs
are mostly responsible for the load support [91, 95, 117]. After the
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release of the load, fluid flows back into cartilage and it swells back
to its original volume. Since the fluid flow has an important role in
the mechanical behaviour of the cartilage, poroelasticity describes
better the behaviour of cartilage than viscoelasticity [113].
Computational biomechanical models of articular cartilage can
be exploited to better understand the biomechanical behaviour and
properties of articular cartilage [76,207]. The biphasic mixture model
of cartilage, which separates fluid and solid phases, was introduced
in 1980 [120]. It is essentially analogous to the poroelastic theory
introduced in 1941 [22]. In 1991, a triphasic mixture model was
introduced, which includes solid, fluid, and ionic phases [96]. Carti-
lage has also been modeled as a poroviscoelastic [172], transversely
isotropic [38], and conewise linear elastic [166] material. In the late
1990’s the first fibril-reinforced model including the collagen network
and poroelastic matrix (PGs and fluid) was developed [103]. Later,
fibril-reinforced poroelastic model was extended to fibril-reinforced
poroviscoelastic [206] and fibril-reinforced poroviscoelastic swelling
models [205].
2.3 OSTEOARTHRITIS
Osteoarthritis (OA) is the most common disease in synovial joints,
most often found in the knee, hip, spine, foot and hand joints [31].
It is characterized by pain, stiffness and decreased mobility, and
thus diminishes the ability to function and the quality of life of a
patient. Both men and women suffer from OA, which becomes more
common with age [126]. OA is a costly disease for society, not only
because of the expensive surgical treatments, but also due to the
need for OA-based disability pensions [68].
2.3.1 Etiology
The reasons that lead to the development of OA are not fully under-
stood [32]. In OA, a progressive loss of articular cartilage is accom-
panied by attempted repair of the cartilage, remodeling and sclerosis
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of subchondral bone, and the formation of bone cysts and marginal
osteophytes [30]. Most commonly, OA develops with increasing age
without any clear cause. This is referred to as primary OA. Instead,
secondary OA develops as a result of an injury, infection or some
developmental or hereditary reasons such as an abnormal shape of
a joint [30]. In addition to age, obesity and excessive mechanical
loading are important risk factors of OA [32, 51, 158].
The earliest degenerative changes in articular cartilage include
loss of PGs and an increase in water concentration [31, 111]. Alter-
ations in the collagen network cause swelling of the tissue [30, 31].
These changes increase the permeability and decrease the stiffness
of cartilage, which in turn can accelerate the rate of degeneration.
Visual changes of the cartilage include fibrillation of the superficial
tissue and thinning of cartilage which eventually leads to a loss of
cartilage, exposing the underlying subchondral bone [31]. Some of
the aforementioned degenerative changes are difficult to separate
from normal age-related changes in articular cartilage [24, 111].
Chondrocytes detect the degenerative changes in cartilage, and to
some extent can stabilize or even restore the tissue [30,31]. However,
when the degradative processes overwhelm the reparative efforts,
chondrocytes fail to protect the tissue from further damage [121].
Alterations in the subchondral bone include thickening of sub-
chondral plate, increased density of the subchondral trabecular
bone, formation of cysts, and appearance of subchondral carti-
lage [30, 31, 59]. According to some speculations OA starts in sub-
chondral bone in a way that stiffening of the bone causes increased
loading of cartilage [53, 59, 142]. Bone cells (i.e. osteoblasts and
osteoclasts [169]) react more rapidly and effectively than chondro-
cytes to changes in the biomechanical environment by remodeling
and modeling. This difference in adaptive capacity of bone and
cartilage affects the physiological relationship between these tissues
contributing to the further development of OA [59].
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2.3.2 Diagnostic methods
Diagnosis of OA is based on the symptoms of the patient and
findings in clinical examination, such as palpable effusion or visible
malalignment of the joint [4, 99]. In radiographically defined OA
narrowing of the joint space, increased density of subchondral bone
or presence of osteophytes are visible in plain radiographs [32].
Patients having both clinical symptoms and radiographic evidence
of OA are considered to have symptomatic OA [99]. In the following
sections, conventional methods to diagnose OA are reviewed and
new techniques still under development are introduced.
Radiography is a conventional way to diagnose OA. The Kellgren-
Lawrence grading system is widely used to evaluate the severity of
OA from plain radiographs [80]. In this system, the formation of
osteophytes, narrowing of joint space, sclerosis of subchondral bone
and possible changes in the shape of the bone ends are evaluated
[80]. Unfortunately, these changes are signs of OA that has already
extensively developed and little can be done to save the joint from
further damage. Furthermore, the symptoms of the patient and
the radiographic findings do not always correlate [32, 112]. Even
though CT provides three-dimensional (3D) imaging of the knee
joint, it suffers from the same disadvantages as plain radiography:
its inability to image cartilage and to detect early changes in OA [35].
Arthroscopy is an invasive method which allows a visual in-
spection of the cartilage surfaces. It is not generally used for the
diagnostics of OA but for the evaluation of cartilage lesions it serves
as the gold standard [168]. Cartilage lesions can be classified in
different ways e.g. according to the International Cartilage Repair
Society scoring system which focuses on the lesion depth and the
area of damage [28]. However, this grading system has been re-
ported to suffer from a high degree of inter- and intraobserver
variability [167, 168].
MRI with properly chosen imaging sequences enables imaging
of cartilage morphology, and can detect changes in subchondral
bone and meniscal abnormalities [41, 67]. However, its rather poor
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spatial resolution, high costs and long acquisition times limit its use
in the diagnostics of cartilage injuries and degeneration. Quantita-
tive MRI techniques to assess the composition of cartilage are also
available [41]. One of these is delayed gadolinium-enhanced MRI of
cartilage (dGEMRIC) which has been proposed to provide a quanti-
tative estimation of the GAG concentration in cartilage [18, 176, 202].
dGEMRIC is based on the assumption that the anionic gadopentetate
(Gd-DTPA2−) molecule is distributed in cartilage, at equilibrium,
in an inverse manner to the GAG concentration. However, it has
recently been reported that the equilibrium partitioning is not achiev-
able in vivo, meaning that the technique is sensitive to other factors
affecting diffusion, e.g. mechanical injury [66, 87, 152, 171].
Ultrasonography (US) of the joints is a non-invasive low-cost
imaging method that enables visualization of articular surfaces and
the contours of the subchondral bone. Thinning of cartilage, thick-
ening of the synovial membrane and effusion of the joint can also
be detected by US. The main limitations of the technique are its in-
ability to image some of the weight bearing areas due to shadowing
by surrounding tissues and its low resolution, not enabling detec-
tion of initial degenerative changes in cartilage and subchondral
bone. [1, 116, 151]
Ultrasound arthroscopy [69, 77, 196] and arthroscopic optical
coherence tomography (OCT) [36, 210] have recently been proposed
for quantitative high resolution imaging of articular cartilage.
2.3.3 Treatment
Currently, there is no treatment effective enough to stop the progres-
sion of OA. However, there are some treatments that can be applied
to improve the quality of life of patients, especially if started early
enough. Treatment options can be divided into nonpharmacologic,
pharmacologic and surgical treatment. [31]
Since obesity is a major risk factor of OA, weight loss can help
to reduce symptoms and may even slow down the progression of
the disease. The exercise program should include range-of-motion
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and stretching exercises, muscle strengthening exercises and aerobic
exercises, but activities involving high loading of the joints should
be avoided [31]. Suitable physical exercise and reduction of obesity
are the most efficient ways to prevent OA [52].
Pharmacologic therapies include analgesics, nonsteroidal anti-
inflammatory drugs and intra-articular injections of steroids and
hyaluronans [141]. Generally, these medications relieve pain but
have virtually no effect to stop the structural degradation of cartilage.
New drugs called disease modifying osteoarthritis drugs (DMOADs)
are under development [141].
There are several surgical procedures that attempt to repair carti-
lage injuries such as bone marrow stimulation [140, 146], autologous
chondrocyte transplantation [27] and autologous osteochondral mo-
saicplasty [65]. Bone marrow stimulation, i.e. microfracturing, is
the most frequently used technique. The technique involves making
multiple holes in the subchondral bone plate through which the
bone cells could enter from the bone marrow into the cartilage lesion.
These cells are able to differentiate into fibrochondrocytes. However,
the subsequent repaired fibrocartilage does not correspond to the
surrounding hyaline cartilage and has less type II collagen. The
healing results have also been reported to deteriorate over time [20].
Autologous chondrocyte transplantation involves at least two
operations, one for tissue harvest and the second for cell transplanta-
tion. First, cartilage slices are obtained from the less weight bearing
locations of the joint of the patient. Then, the cells are isolated and
cultured and finally injected into the lesion under a periosteal flap
which has been sutured to cartilage to cover the lesion [27]. With this
technique, hyaline cartilage can be restored at the repair site [20].
Autologous osteochondral mosaicplasty involves obtaining mul-
tiple small cylindrical osteochondral grafts from the less weight
bearing locations of the joint of the patient and transplanting them
to the cartilage lesion [65]. The procedure can be performed in a
single operation. Transplantation of living hyaline cartilage has led
to encouraging outcomes, eventhough there may be differences in
orientation, thickness and mechanical properties between the donor
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and recipient cartilages [20].
Total knee replacement is a safe and cost-effective treatment for
patients suffering from constant pain not relieved by non-surgical
treatment and with significantly impaired function [127]. About 85%
of patients are satisfied with the results of surgery, but sometimes a
revision operation is needed [127]. According to recommendations
by the Finnish Medical Society Duodecim for the management of
OA, total knee replacement should only be considered as the final
option [47].
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3 Contrast enhanced imaging
of cartilage
The ability of X-ray imaging to differentiate between tissues depend
on differences in their capabilities to attenuate X-rays. Attenuation
depends on the density and atomic number of the tissue in question,
and the energy of the X-rays in use. In a knee joint, there is no natural
contrast between the synovial fluid, cartilage and menisci. Contrast
agents with high atomic numbers can be used to highlight specific
structures in the knee joint. Mostly iodine-based agents are used
in X-ray imaging, due to their solubility and low toxicity [148]. In
MR-imaging, the paramagnetic contrast agent, usually gadolinium-
based, alters the relaxation times of hydrogen atoms within the
tissue, and thus improves contrast. Gadolinium-based contrast
agents are safe to use provided that the patient does not suffer from
kidney disease [188].
3.1 PHYSICS OF CONTRAST AGENT DIFFUSION
Since cartilage is avascular, transport of contrast agents into cartilage
occurs through diffusion. Diffusion is caused by random movement
of the molecules, e.g. ions. If there is a concentration gradient,
diffusion occurs from a higher concentration to a lower one leading
to complete mixing [42]. Before applying the diffusion theory to
cartilage, the basic physics behind equilibrium of ions in a situation
where some ions are not able to diffuse through a semi-permeable
membrane, will be reviewed. The equilibrium in the aforementioned
situation is known as the Donnan equilibrium [45, 58].
Let us consider a bowl with two chambers separated by a semi-
permeable membrane. On side 1, we have a solution containing
permeable potassium ions K+ and impermeable ions, A−. On side
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2, we have potassium chloride (KCl) with permeable ions K+ and
Cl−. At the beginning, the concentrations of the ions are C1 and C2
on sides 1 and 2, respectively.
[K+]1 = [A−]1 = C1 and [K+]2 = [Cl−]2 = C2
Since there are no Cl− on side 1, the concentration gradient forces
Cl− to diffuse from side 2 to side 1.
[Cl−]1 = x and [Cl−]2 = C2 − x
This results in a higher negative charge on side 1, which leads to
the presence of an electrical gradient across the membrane. As a
consequence, K+ starts to diffuse from side 2 to side 1 to balance the
electrical unequilibrium.
[K+]1 = C1 + y and [K+]2 = C2 − y
This, on the other hand, induces a concentration gradient of K+.
At equilibrium, there is no netflow through the membrane, but
the mobile ions, K+ and Cl− continue to diffuse back and forth in
order to balance the concentration and electrical gradients across the
membrane. At equilibrium, both sides are electrically neutral them-
selves, having equal concentrations of cations and anions. Because
of the impermeable anions on side 1, there is a higher concentration
of negative ions on that side and this creates an electrical potential
difference across the membrane. This is called the Nernst potential
which is equal for all mobile ions. Nernst equation is
∆Ψ = −RT
zF
ln
C1
C2
, (3.1)
where R is the gas constant, T is temperature, z is the valency of the
ion, F is the Faraday constant, and C1 and C2 the concentrations of
the ions on sides 1 and 2 of the membrane. By reorganizing equation
(3.1), we have (
C1
C2
) 1
z
= e−
F∆Ψ
RT
= r, (3.2)
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which is known as the Donnan ratio.
At equilibrium in the above example, according to equation (3.2)
it can be seen that
[K+]1
[K+]2
=
[Cl−]2
[Cl−]1
(3.3)
C1 + y
C2 − y =
C2 − x
x
. (3.4)
To maintain the electroneutrality, it must hold that x = y. Thus, if
we solve equation (3.4) for x we have
x =
C22
2C2 + C1
,
and we can write the Donnan ratio for the above example as follows.
r =
[K+]1
[K+]2
=
[Cl−]2
[Cl−]1
=
C1
C2
+ 1 (3.5)
As demonstrated with the previous example, a fixed charge on
one side of the membrane forces the mobile anions and cations to
become unevenly distributed on both sides of the membrane.
If we apply this theory to cartilage tissue, with mobile anions
(An) and cations (Cat) and negative FCD, equilibrated in a bath
containing electrolyte solution with anionic contrast agent (Contrast),
the electrochemical equilibrium requires that(
[An]c
[An]b
) 1
zanion
=
(
[Cat]c
[Cat]b
) 1
zcation
=
(
[Contrast]c
[Contrast]b
) 1
zcontrast
, (3.6)
where z is valency of the ion and subscripts c and b refer to cartilage
and bath, respectively.
In order to satisfy the electroneutrality in the bath and in the
cartilage, the following conditions must be met:
zanion[An]b + zcation[Cat]b = 0 (3.7)
zanion[An]c + zcation[Cat]c + FCD = 0. (3.8)
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It must be noted that in equations (3.7) and (3.8) it is assumed
that the concentration of contrast is negligible as compared to the
concentrations of the mobile anions and cations. By combining
equations (3.6) – (3.8) it is theoretically possible to calculate FCD
from the measured contrast agent concentration and known bath
ionic concentration.
FCD =− zcation
 [Cat] 1zcationb [Contrast] 1zcontrastc
[Contrast]
1
zcontrast
b

1
zcation
− zanion
 [Cat] 1zanionb [Contrast] 1zcontrastc
[Contrast]
1
zcontrast
b

1
zanion
(3.9)
The application of dGEMRIC, which is presented later in this chapter,
is based on reaching the ideal Donnan equilibrium between cartilage
tissue and external fluid [17].
The actual transport via diffusion can be described with Fick’s
laws of diffusion [42]. The Fick’s first law describes steady-state
diffusion, where the solute flux Γ, i.e the number of particles per
second per unit tissue area, is related to the gradient of concentration
C with the diffusion coefficient D:
Γ = −D∂C
∂x
, (3.10)
where C is solute concentration per volume of tissue and x is the
position along the cartilage depth. D is a specific constant for the
solute of interest and the tissue through which it is being transported,
and it determines how quickly an equilibrium concentration can be
achieved in the system [39].
In an unsteady situation, where the concentration gradient at
the diffusion interface is suddenly increased and a time-dependent
concentration profile is produced while the solute penetrates into
the tissue, the Fick’s second law is applicable [42].
∂C
∂t
= −∂Γ
∂x
= −D∂
2C
∂x2
, (3.11)
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Figure 3.1: Cartilage sample equilibrating in a contrast agent bath. Boundary 1 is a
diffusion interface, and boundaries 2–4 are closed with a sample holder.
where t is time and D is assumed to be constant. Considering the
situation with a cartilage sample equilibrating in a bath containing
contrast agent (Figure 3.1), the following boundary conditions apply:
t = 0 [Contrast]c = 0 in the whole sample
t > 0 [Contrast]c = K[Contrast]b for boundary 1
Γ = 0 for boundaries 2, 3 and 4
where t is time and K is the partition coefficient assumed to be
constant as well as the contrast agent concentration in the bath
([Contrast]b). Boundaries 2, 3 and 4 are closed with a special sample
holder. Given these boundary conditions, it is possible to solve equa-
tion (3.11) using finite element analysis (FEA) which is a convenient
tool to numerically solve partial differential equations. By fitting
the model to the concentrations measured e.g. via CT imaging, it is
possible to determine D.
Diffusion and partition of solutes in cartilage depend on many
factors. As can be seen from equation (3.6), the higher the charge
of a particle, the higher the concentration gradient. Indeed, many
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studies have reported the charge dependency of partitions of ionic
and non-ionic contrast agents in cartilage [37, 57, 201]. In addition,
the increasing size of the diffusing molecule has shown a negative
correlation with D in studies with glucose, inulin and dextran [3,100,
101,107,179–182]. The local organization of collagen network has also
an effect on diffusion, resulting in the anisotropic D [101]. The FCD
of cartilage is an evident factor especially controlling the diffusion
of charged solutes, and it correlates negatively with D [106–108].
FCD is also an important determinant of the pore size of the ECM
[108]. Fine pore size due to high PG concentration causes steric
hindrance, and especially large molecules (charged or not) can be
totally excluded from regions with high PG concentrations [107,108].
Variations in the water content are also related to the pore size of
the ECM, and thus increase in water content correlates positively
with D [106, 108].
3.2 DELAYED GADOLINIUM ENHANCED MAGNETIC
RESONANCE IMAGING OF CARTILAGE
In delayed gadolinium enhanced MRI of cartilage (dGEMRIC) dif-
fusion of paramagnetic contrast agent gadopentetate (Gd-DTPA2−)
into cartilage is imaged by determining its effect on tissue T1 relax-
ation time. The basic idea is that the anionic contrast agent will
distribute in cartilage according to the ideal Donnan equilibrium [17],
i.e. in an inverse relation to the distribution of negative FCD induced
by GAGs. Thus, assuming that there is a Donnan equilibrium be-
tween cartilage tissue and external fluid, it is theoretically possible
to calculate FCD in cartilage according to equation (3.9).
Making the following annotations
Cat = Na+ zcation = 1
An = Cl− zanion = −1
Contrast = Gd-DTPA2− zcontrast = −2
and adding a corrective factor of 2 [18] we end up with the following
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equation for FCD in cartilage:
FCD = 2[Na+]b
(√
[Gd-DTPA2−]c
[Gd-DTPA2−]b
−
√
[Gd-DTPA2−]b
[Gd-DTPA2−]c
)
, (3.12)
where subscripts c and b refer to cartilage and bath, respectively.
The concentration of sodium may be measured by nuclear magnetic
resonance (NMR) spectroscopy [102]. The concentrations of Gd-
DTPA2− can be determined as follows:
[Gd-DTPA2−] =
1
R
(
1
T1,Gd
− 1
T1,0
)
, (3.13)
where R is the relaxivity, T1,Gd and T1,0 are the relaxation times
measured in presence and absence of Gd-DTPA2−, respectively. In
current practice, the T1,Gd, referred to as dGEMRIC-index, or change
in relaxation rate (∆R1, expression in parentheses in equation (3.13))
is reported.
dGEMRIC has been widely studied in vitro [2, 10, 17, 18, 84, 94,
98, 129–131, 153, 185, 197, 208] and in vivo [16, 56, 93, 114, 125, 128,
132, 134, 159, 173–178, 183, 184, 198, 202–204]. The in vitro results
have revealed high correlations between the GAG concentration
and T1,Gd [17, 18, 84, 129, 131, 197, 208]. However, the validity of the
technique has been recently questioned [66, 152, 171] if one uses it
to try to achieve a quantitation of cartilage GAG content in vivo.
The challenge with dGEMRIC is that the equilibrium partitioning
may not be reached in vivo due to slower diffusion of Gd-DTPA2−
into cartilage than had been assumed [152, 164] and partly due
to washout of the contrast agent before an equilibrium has been
reached in deep cartilage [66].
3.3 CONTRAST ENHANCED COMPUTED TOMOGRAPHY
Contrast enhanced computed tomography (CECT) is an X-ray tech-
nique analogous to dGEMRIC [37,135]. Similarly as with dGEMRIC,
there are several successful in vitro studies where the relationship be-
tween anionic contrast agent concentration and GAG concentration
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in cartilage has been shown [13,37,79,135,163–165,209]. The contrast
agent concentration measured with CECT has also been shown to
correlate with the cartilage biomechanical properties [9, 13]. How-
ever, it has been reported that the diffusion time for contrast agent
to reach the equilibrium may well be several hours, which suggests
that it cannot be reached in clinical settings [79, 163–165, 199].
According to an earlier study [164], GAG and contrast agent
concentrations have correlated already before the equilibrium has
been reached. In addition, CECT has enabled the detection of
cartilage injuries already after 30–60 minutes of diffusion [87]. These
results imply that imaging of diffusion dynamics instead of the
situation at equilibrium may enable evaluation of cartilage integrity.
Recently, a new cationic iodinated contrast agent (CA4+) has
been introduced to be used in CECT [75] and it has been evaluated
in vitro [14, 15, 97] and in vivo in rabbits [170]. Carrying a positive
charge of 4 it is effectively attracted by the GAGs and accumulates
in higher concentrations in cartilage compared to anionic contrast
agents and this makes easier the segmentation of cartilage [14, 15, 75,
170]. CA4+ has been shown to provide a better correlation between
contrast agent and GAG concentrations than anionic contrast agents
[14, 15]. Similar to the situation of CECT with anionic contrast
agents, CECT with CA4+ has also been reported to correlate with
the biomechanical properties of cartilage [97].
The capability of CECT to detect cartilage degeneration has been
investigated in vivo in small animal models, and the method has
been able to distinguish between healthy and degenerated carti-
lage [138, 139, 161]. These animal studies and ex vivo studies on
cadaveric knee joints have reported encouraging results showing
that CECT provides valuable information on cartilage status even
without reaching the diffusion equilibrium [160, 189].
X-ray arthrography has been in clinical use for decades [23, 105,
136, 143]. Contrast agents have been used to visualize cartilage
morphology and superficial lesions, and to assess the menisci and
ligaments [5, 44, 55, 147, 190]. In contrast to arthrography, a delay
between the contrast agent injection and image acquisition is ap-
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plied in delayed quantitative CT arthrography (dQCTA i.e. in vivo
application of CECT). The clinical potential of this technique has
been recently investigated for the first time [86]. In that study, the
contrast agent concentration in cartilage that was normalized with
the concentration in the synovial fluid was higher in an OA knee
than in a healthy knee at 30 minutes after intra-articular injection of
anionic contrast agent. Since each patient has a different amount of
synovial fluid which dilutes the injected contrast agent, it is difficult
to decide on the optimal amount and concentration of the contrast
agent in order to provide the best possible diagnostic quality.
In addition, the minimum number of acquisitions needed in
dQCTA is still unclear. Three acquisitions were proposed by Kokko-
nen et al. [86]: one before contrast agent injection (non-contrast
image), one after the injection followed by a few minutes of light
exercise of the joint to aid distribution of the contrast agent (arthro-
graphic image), and one at 30–60 minutes after the injection (delayed
image). By subtracting the non-contrast image from the arthro-
graphic and delayed images, it is possible to determine the absolute
contrast agent concentration in cartilage in these two time points.
However, considering the radiation dose, acquisition of the non-
contrast image may not be always acceptable. It is possible that
the amount of contrast agent penetrating to cartilage between the
acquisitions of the arthrographic and delayed images could serve as
an adequate indicator of the state of the cartilage (Figure 3.2) [85].
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Figure 3.2: Examples of dQCTA images of human tibiofemoral joint [85]: A) arthrographic
image with clearly visible superficial lesions, B) delayed image acquired at 45 min after
contrast agent injection, and C) subtraction image which is acquired by subtracting the
arthrographic image from the delayed image. The high contrast agent concentration
visualized in the figures B and C is indicative of poor cartilage quality.
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4 Aims of the present study
In this thesis the diffusion of X-ray contrast agents in cartilage was
investigated in vitro and in vivo. The aim was to assess the effects of
cartilage integrity and composition on contrast agent diffusion and
to investigate the diagnostic potential of contrast enhanced CT.
The specific aims of this thesis were
1. to determine the tissue-averaged axial diffusion coefficients
for four different CT and MRI contrast agents and to compare
diffusion through the articular surface with diffusion through
deep cartilage.
2. to investigate the ability of microCECT to distinguish sponta-
neously healed osteochondral lesions from normal cartilage
tissue in equine intercarpal joint.
3. to determine the individual contribution of cross-linking in-
duced increases in FCD and steric hindrance to the change in
the partition of clinical X-ray contrast agents in cartilage.
4. to compare dGEMRIC and dQCTA with each other, and their
association to the arthroscopic findings in human knee joints
in vivo.
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5 Materials and methods
This thesis consists of four independent studies (I–IV). The materials
and methods used in the studies are summarized in Table 5.1. The
experimental CECT data in study I was obtained from an earlier
study by Silvast et al. [165]. The rest of the data is original.
Table 5.1: Summary of materials and methods used in studies I–IV.
Study Species and tissue Number of
samples or
patients
Methods
I Bovine cartilage n = 6 per group
4 groups
CECT
FE analysis of diffusion
II Horse cartilage and
subchondral bone
n = 7 microCECT
FE analysis of diffusion
Mechanical testing
FE analysis of cartilage
deformation under load
Histological analysis
III Bovine cartilage n = 6 in group I
n = 7 in group II
microCECT
Biochemical analysis
Histological analysis
IV Human cartilage
in vivo
n = 11 dQCT
dGEMRIC
Arthroscopy
5.1 SAMPLE PREPARATION
The bovine knees for studies I and III were acquired from a local
abattoir (Atria Oyj, Kuopio, Finland). The samples were detached
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from upper lateral quadrant of visually intact patellae. In study
I, eight adjacent full-thickness (1.3± 0.1 mm, mean± SD) cartilage
discs (diameter 4 mm) were detached from patellae and randomly
divided into four groups according to the contrast agent to be used
in CECT imaging [165].
In study II, osteochondral lesions (diameter 6 mm) were sur-
gically created in the intercarpal joints of horses under general
anesthesia. After 12 months of spontaneous healing, the horses were
sacrificed, and osteochondral plugs (diameter 14 mm) were har-
vested. The plugs included the repair cartilage and intact adjacent
tissue. The procedures were approved by the Utrecht University
Animal Experiments Committee.
In study III, cylindrical plugs (diameter 24.5 mm) were drilled
from the upper lateral quadrant of bovine patellae and cut into
four pieces. Osteochondral samples (diameter 6 mm) were punched
from each piece, and divided into two groups according to the
contrast agent to be used in CECT imaging. One of the paired
samples served as a reference while the other was treated with
threose (Sigma Aldrich Co., St. Louis, MO, USA) to induce collagen
cross-linking, which resembles the process of natural ageing. The
samples were incubated in humidified 5%CO2/95% air atmosphere
at 37◦C for seven days.
Study IV involved contrast enhanced CT and MR imaging of
human patients (n = 11) referred to an arthroscopic surgery of the
knee. One patient declined to undergo arthroscopy but completed
all imaging studies. One patient was excluded from the analysis due
to irregular distribution of contrast agent in the joint. An informed
consent was obtained from all patients. The study was approved
by the Ethical Committee of the Northern Ostrobothnia Hospital
District, Oulu, Finland (No. 33/2010).
The rather low number of samples in the studies was accepted
for practical reasons. However, it was ensured that in the in vitro
studies the control and experimental samples were paired, and the
test groups included independent sample pairs.
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5.2 CONTRAST ENHANCED CT
Contrast enhanced imaging experiments were conducted with three
different scanners. A peripheral quantitative CT (pQCT) scanner
was used in study I, microCT was used in studies II and III, and a
clinical 64-slice CT scanner was used in study IV (Table 5.2).
Table 5.2: Imaging scanners and parameters used in studies I–IV.
Scanner Voxel size Tube
voltage or
field
strength
Imaging time points
pQCT 200 × 200 µm2 58 kV 1, 5, 9, 16, 25, 29 h a
slice thickness: 2.3 mm
microCT 29.8× 29.8× 29.8 µm3 100 kV Study II: Continuously
for 2.5 h, 3, 4, 5, 6, 7, 8, 9,
10, 11, 12, 24, 26, 28, 30,
32, 34, 36 h a
Study III: 5 min, 24 h a
CT 312× 312× 312 µm3 100 kV 5, 45 min
MR 469 × 469 µm2 3 T 90 min a
slice thickness: 3.0 mm
aPre-contrast image was acquired.
5.2.1 Peripheral quantitative CT
A clinical pQCT scanner (XCT 2000, StraTec Medizintechnik GmbH,
Pforzheim, Germany) was used in study I. Tube voltage of 58.0 kV,
slice thickness of 2.3 mm and in-plane pixel size of 200 × 200 µm2
were applied. Diffusion of four different contrast agents (ioxaglate,
gadopentetate, iodide, gadodiamide, Table 5.3) was investigated for
29 h. One of the paired cartilage discs was mounted in the sample
holder in a way that diffusion was allowed through the articular
surface, and the other disc in a way that diffusion was allowed
through the deep cartilage. The samples were first imaged without
contrast agent, and after immersion in the contrast agent bath at
the following time points: 1, 5, 9, 16, 25 and 29 h. The final data
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matrix for FEA of diffusion contained concentration values of each
depth-wise pixel layer at different time points. Data analysis was
performed using MATLAB (v. R2007b, MathWorks Inc., Natick, MA,
USA).
5.2.2 X-ray microtomography
CECT measurements in studies II and III were conducted with a
microCT instrument (SkyScan-1172; SkyScan, Kontich, Belgium)
with X-ray tube voltage of 100 kV and an isotropic voxel size of
29.8× 29.8× 29.8 µm3. In study II, the samples were first imaged
without contrast agent (ioxaglate, Table 5.3). After immersion into
the contrast agent, the samples were continuously imaged for 2.5
h and then at the following time points: 3, 4, 5, 6, 7, 8, 9, 10, 11,
12, 24, 26, 28, 30, 32, 34 and 36 h. In study III, the samples were
first imaged when immersed in phosphate buffered saline (PBS)
containing inhibitors of metalloproteinases. Then, after replacing
PBS with contrast agent (ioxaglate and iodixanol, Table 5.3), the
samples were imaged after 5 min of immersion. Finally, the samples
were imaged after 24 h of immersion.
In study II, a 1-mm-thick coronal slice at the middle of the lesion
was extracted for further analysis. The linear attenuation coefficient
was measured for two regions of interest (ROIs): one in the middle
of the repaired cartilage and another in the adjacent intact cartilage.
For the analysis of the subchondral bone, two cylindrical ROIs
(diameter: 3 mm, height: 2 mm) were extracted below the repair and
adjacent intact tissue. A global threshold technique was applied in
the segmentation of the bone [150]. The following parameters were
defined: bone volume fraction (bone volume (BV) / tissue volume
(TV), %), bone surface to volume ratio (BS/BV, 1/mm) and bone
mineral density (BMD, g/cm3). The analysis was conducted with
CT Analyser software (v. 1.10.1.0; SkyScan).
In study III, the full cartilage thickness ROI was placed to the
middle of the sample (average of 100 coronal slices, width of 100
pixels). A depth-wise X-ray absorption profile was achieved by
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averaging the pixel rows of the ROI. The actual contrast agent dis-
tribution after 24 h immersion time was determined by subtracting
the pre-contrast profile from the profile acquired at 24 h. The con-
trast agent concentration in cartilage was normalized against the
contrast agent concentration in the immersion solution. Analyses
were conducted with custom MATLAB (version R2010a, MathWorks
Inc., Natick, MA, USA) scripts.
5.2.3 Delayed quantitative CT arthrography
In study IV, each knee was imaged with a clinical 64-slice CT scanner
(DiscoveryTM PET/CT 690, GE Medical Systems, Waukesha, WI,
USA) with X-ray tube voltage of 100 kV and an isotropic voxel size
of 312× 312× 312 µm3. Before CT scan, the ioxaglate – Gd-DTPA2−
contrast agent mixture (Table 5.3) was injected intra-articularly. Gd-
DTPA2− was included into the mixture as the patients were also MR
imaged using the dGEMRIC protocol. Between the injection and
imaging, the patient performed active flexion-extension exercises of
the knee for 5 minutes to enable effective distribution of the contrast
agent into joint surfaces. The CT scan at 5 minutes after injection
corresponded a conventional CT arthrography. Another time point
at 45 minutes was selected based on a previous study [86] suggesting
that the maximum contrast agent concentration in cartilage can be
achieved between 30 and 60 minutes after injection.
dQCTA analysis was conducted with Analyze software (Ana-
lyze 10.0, AnalyzeDirect, Inc., Overland Park, KS, USA). Seven 3D
cartilage ROIs were extracted: medial condyles of tibia and femur
(TMC and FMC), lateral condyles of tibia and femur (TLC and FLC),
medial and lateral trochlear grooves (MTG and LTG) and patella
(PAT). In addition, a ROI from the largest and clearest synovial fluid
(SF) volume was selected. The mean X-ray attenuation values of
the cartilage and SF ROIs at 5 and 45 minutes after contrast agent
injection were calculated. Contrast agent concentrations in SF were
used to normalize the cartilage parameters.
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5.3 DELAYED GADOLINIUM-ENHANCED MRI
OF CARTILAGE
In study IV, each knee was imaged three times using a 3T MR
scanner (Siemens Skyra, Siemens Healthcare, Erlangen, Germany)
(Table 5.2). In the first session, pre-contrast T1 mapping (single-slice,
medial and lateral condyles) was performed before intravenous (IV)
injection of 0.2 mmol/kg of Gd-DTPA2− (Table 5.3). Subsequently,
patient performed active flexion-extension exercises of the knee for
5 minutes and walked for 5 minutes. T1 mapping was repeated at
90 minutes after the IV injection [43, 176].
Two weeks later, T1 mapping was performed after intra-articular
(IA) injection of ioxaglate – Gd-DTPA2− contrast agent mixture
(Table 5.3). Ioxaglate was included in the mixture, as the knees were
also CT imaged using the dQCTA protocol. Again, the post-contrast
T1 mapping was performed at 90 minutes after the IA injection.
T1 maps were generated using an in-house application created
with MATLAB (version 7.9.0; MathWorks inc., Natick, MA, USA).
Six ROIs were extracted from manually segmented cartilage (MTG,
LTG, TLC, FLC, TMC and FMC) and one ROI from SF. Patella was
not properly visualized in the dGEMRIC images, and was excluded
from the analyses. The mean T1 relaxation time (i.e. dGEMRIC-
index) was calculated for each cartilage ROI. In addition, ∆R1 was
calculated for each ROI (equation 5.1).
∆R1 =
(
1
T1,Gd
− 1
T1,0
)
(5.1)
5.4 ARTHROSCOPY
In study IV, routine arthroscopic examination of the knee was con-
ducted for the patients after dQCTA and dGEMRIC. The cartilage
appearance at predetermined sites of knee joint (TMC, FMC, TLC,
FLC, MTG, LTG and PAT) was classified according to the Interna-
tional Cartilage Repair Society (ICRS) grading system [28] by an
experienced orthopaedic surgeon (Table 5.4).
Dissertations in Forestry and Natural Sciences No 110 33
Katariina Nissinen: Diffusion of contrast agents in cartilage
Table 5.4: ICRS classification.
ICRS grade Cartilage appearance
0 Normal
1 Nearly normal. Superficial lesions, soft indentation
and/or superficial fissures and cracks.
2 Abnormal. Lesions extending down to <50% of
cartilage depth.
3 Severely abnormal. Cartilage defects extending
down to >50% of cartilage depth as well as down
to calcified layer and down to but not through the
subchondral bone. Blisters are included in this
grade.
4 Severely abnormal.
5.5 SIMULATION OF CONTRAST AGENT DIFFUSION
In study I, the distribution of contrast agent in cartilage was simu-
lated with a one-dimensional (1D) FE model (COMSOL 3.5, COM-
SOL Inc., Burlington, MA, USA). The length of the 1D FE-geometry
corresponded to each cartilage disc thickness obtained from pQCT
images. The FE-geometry consisted of 15 1D-elements evenly dis-
tributed along the cartilage depth. The COMSOL software solves
diffusive mass transport from the Fick’s second law (equation 3.11).
Diffusion was allowed only from one side of the sample (superfi-
cial/deep cartilage), and the contrast agent concentration on that
diffusion interface was assumed to be constant. To determine the
diffusion coefficient (D), the model was fitted to the experimentally
determined contrast agent concentration averaged over the full tissue
depth at each time point. The unconstrained nonlinear minimization
routine of MATLAB (version R2007b; The MathWorks Inc., Natick,
MA, USA) was used for optimization of the diffusion coefficient and
the concentration on the diffusion interface by minimizing the mean
square error between the experimental and simulated concentrations
at different time points.
In study II, D of contrast agent was determined as described
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above, but based on the average values of the linear attenuation
coefficient at each time point.
5.6 REFERENCE METHODS
In studies II and III, the CECT parameters were compared with the
reference histological (II and III), biochemical (III) and mechanical
(II) parameters of cartilage. Histological analyses included polarized
light microscopy (PLM) (II), digital densitometry (DD) (II and III)
and Fourier transform infrared imaging (FTIRI) (III). The reference
methods will be described in the following sections.
5.6.1 Histological and biochemical analyses
In study II, samples were prepared after the CECT experiments for
histological analyses including PLM of collagen fibril orientation
and DD of FCD distribution. In study III, the samples were cut into
two halves. One half was prepared for the biochemical analysis of
water content, collagen and cross-link concentrations, and the other
for histological analysis of the FCD distribution with DD, and PG
and collagen distributions with FTIRI.
Before the preparation of the microscopy sections, samples were
fixed in 10% formalin for 48 hours, decalcified with 10% EDTA
and 4% formaldehyde in 0.1 mol/L sodium phosphate buffer, and
embedded in paraffin. 3- µm-thick sections were used in DD, 5-
µm-thick sections in FTIRI, and 7- µm-thick sections in PLM.
Safranin O -stained sections were used to determine FCD distri-
bution in cartilage samples by means of DD [82, 83]. A CCD-camera
(CH250, Photometrics, Tucson, AZ) was used for the measurements
of the optical density of the Safranin O -stained sections.
PLM measurements of collagen fibril orientation angle and paral-
lelism index (PI) maps were conducted for unstained sections using
a Leitz Ortholux BK II POL microscope (Leitz Wetzlar, Wetzlar, Ger-
many) [144]. The orientation angle is defined as the angle between
the articular surface and the long axis of a fibril. PI describes the de-
gree of structural anisotropy of collagen fibril network. The highest
Dissertations in Forestry and Natural Sciences No 110 35
Katariina Nissinen: Diffusion of contrast agents in cartilage
PI is evidence of a structure where collagen fibrils are oriented in
the same direction, whereas the lowest PI value indicates randomly
organized collagen fibrils.
Spatial distributions of the PG and collagen concentrations of
cartilage samples were determined with FTIRI using the Perkin
Elmer Spotlight 300 FTIRI system (PerkinElmer, Shelton, CO, USA)
[34, 145]. The absorption spectra of the collagen and PG were at
1585–1720 cm−1 and 984–1140 cm−1, respectively.
The water content of the samples was determined from the dif-
ference between the wet weight and dry weight after freeze-drying.
Subsequently, the samples were hydrolyzed with hydrochloric acid
(HCl). After this and drying by evaporation and dissolving the
samples into water, the spectrophotometric assay for collagen spe-
cific amino acid hydroxyproline was performed for the estimation
of the collagen concentration [40]. High-performance liquid chro-
matography was used to measure the concentrations of hydroxyly-
sylpyridinoline (HP), lysylpyridinoline (LP) and pentosidine (Pent)
cross-links [12, 89].
5.6.2 Mechanical testing
In study II, the samples were mechanically tested using a custom-
made material testing device (Figure 5.1) which consisted of a load
cell (Sensotec, Columbus, OH, USA), a precision motion controller
(PM500-C, Newport, Irvine, CA, USA) and a computerized data
acquisition system [187]. Mechanical measurements were carried
out using a stepwise (3 steps) creep indentation protocol [120]. The
first step was considered a pre-step to confirm full contact between
cartilage and impermeable, plane-ended indenter (radius: 272 µm).
The stress was increased by 84 kPa in every step, and the deformation
after each step was recorded for 1200 seconds.
The experimental creep behaviour of each sample was analyzed
using the finite element method (FEM). The aim was to find out
the specific contributions by the GAGs, collagen network, and fluid.
To achieve this, a fibril-reinforced poroelastic model [91, 103] was
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Figure 5.1: A) Schematic illustration of the custom made material testing device. B) In
creep measurement, the deformation is recorded while applying a constant load.
constructed using Abaqus (version 6.9 EF1; Dassault Systémes Simu-
lia Corp., Providence, RI, USA). Articular cartilage was modeled as
a biphasic material consisting of solid and fluid phases. The fluid
fraction was adjusted to 85 % [91, 103]. The solid phase consisted
of a non-fibrillar and fibrillar part corresponding to the mechan-
ical effects of GAGs and the collagen network, respectively. The
non-fibrillar matrix was assumed to be hyperelastic (neo-Hookean)
characterized with Young’s modulus Enf and Poisson’s ratio ν. The
Poisson’s ratio of the non-fibrillar matrix was fixed to be 0.42 in
all analyses [91, 103]. The behaviour of the collagen fibrils was ex-
pressed with the fibril network modulus Ef, and the fluid flow was
described with the permeability k.
Cartilage geometry was constructed with axisymmetric 4-node
continuum elements with pore pressure. Cartilage edge and surface
(except for the cartilage-indenter contact) were set to be permeable
(zero pore pressure). The bottom of the cartilage was fixed in x-
and y-directions, and the movement at x-direction was prevented
at the axis of symmetry. The indenter was modeled as a linearly
elastic material (E: 60 GPa, ν: 0.3), and the cartilage-indenter contact
was assumed to be frictionless. The step stress, implemented in
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the model as a contact stress between cartilage and indenter, and
creep time were the same as in the experiments. The thickness
of cartilage layer of each sample was obtained from the microCT
images. The unconstrained nonlinear optimization routine of the
Matlab Optimization Toolbox (version R2007b; The MathWorks, Inc.,
Natick, MA) was used to fit the following parameters: En f , E f , and
k. During fitting, the mean square error between the experimental
and simulated displacements was minimized.
5.7 STATISTICAL ANALYSES
The non-parametric Wilcoxon signed-ranks test was applied for
all statistical comparisons in studies I, II and III. The differences
between the diffusion coefficients of different contrast agents and
different diffusion directions were compared in study I. In addition,
false discovery rate control was used to adjust for multiple compar-
isons. The differences between the parameter values determined for
the repair tissue and the adjacent intact tissue were compared in
study II. In study III, the differences between the properties of the
reference and threose treated samples were compared. Spearman’s
correlation coefficients were determined between different parame-
ters in studies II and III. Either Spearman’s or Pearson’s correlation
coefficient was determined in study IV, depending on the normality
of the distribution of parameter value tested using the Kolmogorov-
Smirnov test. The statistical significances of differences between
the correlation coefficients were tested using the Fisher’s transform,
and group comparisons were performed with the Kruskal-Wallis
test in study IV. SPSS (version 14.0 SPSS Inc., Chicago, IL, USA),
IBM SPSS Statistics (IBM SPSS Statistics 19.0.0.1, SPSS Inc., IBM
Company, Armonk, NY, USA), R (version 2.7.2 the R Foundation
for Statistical Computing, Vienna, Austria) and MATLAB (version
R2010a, MathWorks Inc.) were used in statistical analyses.
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6 Results
The most important results of studies I–IV are summarized in this
chapter. The more detailed results can be found in the original
publications in the appendices.
6.1 CONTRAST AGENT DIFFUSION THROUGH
SUPERFICIAL AND DEEP CARTILAGE
In study I, diffusion coefficients of four contrast agents in full-
thickness cartilage were determined by analyzing CECT images
by using the finite element method. Diffusion was significantly
(p < 0.05) faster through articular surface than through deep car-
tilage with all contrast agents except for iodide (Table 6.1). The
simulated concentration values were in accordance with the experi-
mental counterparts (Figure 6.1).
Table 6.1: Diffusion coefficients (mean ± SD) in articular cartilage for four contrast agents
with different mass and charge. Diffusion was significantly faster through articular surface
than through deep cartilage with gadopentetate, gadodiamide and ioxaglate. Iodide diffused
significantly faster than ioxaglate and gadodiamide through the articular surface. Through
deep cartilage, iodide diffused significantly faster than all the other contrast agents. (Study
I)
Diffusion coefficients (µm2/s)
Contrast agent (mass, charge) Superficial to deep Deep to superficial
Iodide (127 g/mol, −1) 474.7± 251.7 292.3± 80.5
Gadopentetate (548 g/mol, −2) 253.7± 224.6∗ 42.6± 45.2
Gadodiamide (574 g/mol, 0) 161.1± 52.2∗ 53.9± 17.4
Ioxaglate (1269 g/mol, −1) 142.8± 62.8∗ 41.8± 52.6
∗p < 0.05 Wilcoxon signed-ranks test, n = 6 for each group.
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Figure 6.1: Experimental (mean ± SD) and simulated normalized contrast agent concen-
trations as a function of time. A) The contrast agent was allowed to penetrate through the
articular surface (n = 6 for each contrast agent). B) The contrast agent was allowed to
penetrate through deep cartilage (n = 6 for each contrast agent). (Study I) In the original
publication I the caption of Figure 2 mistakenly indicates that the contrast agent would
have been allowed to penetrate through the articular surface in six samples. In reality,
the data in Figure 2 includes all the samples (n = 12 for each contrast agent) and both
diffusion directions. (Study I)
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6.2 CECT OF SPONTANEOUSLY REPAIRED
OSTEOCHONDRAL INJURIES
The diffusion coefficient of ioxaglate was significantly (p < 0.05)
higher in spontaneously repaired equine cartilage than in the adja-
cent intact tissue. However, contrast agent concentration in equilib-
rium (i.e. X-ray attenuation) was not significantly different between
repaired and intact tissue. The structure and density of the sub-
chondral bone under repaired and intact cartilage were significantly
(p < 0.05) different. The moduli of the nonfibrillar matrix and the
fibril network of the repair cartilage were significantly (p < 0.05)
inferior to those determined for the adjacent intact tissue (Table
6.2). Collagen fibril orientation and parallelism, and optical den-
sity describing the GAG content of the tissue revealed also inferior
quality of the repair cartilage (Figure 6.2). The contrast agent dif-
fusion coefficient correlated significantly with the modulus of the
nonfibrillar matrix (R = −0.66, p < 0.01) and the parallelism index
(R = −0.59, p < 0.05).
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Table 6.2: Properties of spontaneously repaired cartilage and subchondral bone under
repair cartilage (mean ± 95% confidence interval) were significantly different from those of
adjacent intact tissue. (Study II)
Intact (n = 7) Repair (n = 7)
D (µm2/s) 29.3 (7.59, 50.9) 107.9 (62.4, 153.3)∗
Enf (MPa) 0.65 (0.47, 0.83) 0.15 (0.08, 0.22)∗
Ef (MPa) 10.1 (8.08 12.0) 4.70 (2.21, 7.19)∗
αde(1 · 10−3/cm) 0.83 (0.74, 0.93) 0.75 (0.69, 0.82)
αnc(1 · 10−3/cm) 0.69 (0.58, 0.80) 0.55 (0.47, 0.63)
BV/TV (%) 87.2 (81.2, 93.1) 67.7 (55.8, 79.7)∗
BS/BV (1/mm) 5.12 (3.90, 6.34) 9.39 (7.04, 11.7)∗
BMD (g/cm3) 0.84 (0.81, 0.86) 0.72 (0.69, 0.74)∗
D=Diffusion coefficient, Enf=Modulus of the nonfibrillar matrix,
Ef=Modulus of the fibril network, αde=Attenuation coefficient in dif-
fusion equilibrium, αnc=Attenuation coefficient in native cartilage,
BV/TV=Bone volume fraction (Bone volume/tissue volume), BS/BV=Bone
surface/volume ratio, BMD=Bone mineral density, ∗p < 0.05 Wilcoxon
signed-ranks test
6.3 EFFECT OF COLLAGEN CROSS-LINKING ON
CONTRAST AGENT DIFFUSION
In study III, the concentrations of the pentosidine and lysylpyridi-
noline cross-links were significantly (p < 0.05, n = 13) higher in
the threose-treated samples. The partition of anionic ioxaglate was
significantly (p < 0.05, n = 7) lower in the threose-treated than in
the reference samples, while the threose-treatment did not affect the
partitioning of the non-ionic iodixanol (Figure 6.3). The FCD was
elevated significantly (p < 0.05, n = 13) after the threose-treatment
in the middle and deep zones of cartilage. However, there was no
systematic difference in the GAG concentration of the reference and
treated samples.
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Figure 6.2: Orientation angle (A) and parallelism index (B) of collagen fibrils and optical
density (C) indicating spatial glycosaminoglycan content (mean± 95% confidence interval).
Significant statistical difference (p < 0.05, Wilcoxon signed-ranks test) between repair and
adjacent intact tissue is marked with ∗. (Study II)
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Figure 6.3: A) Partition of anionic ioxaglate in the threose-treated samples was significantly
lower than that in the reference samples through the entire tissue depth. ∗p < 0.05, n = 7
B) There was no cross-linking induced difference in partition of iodixanol (n = 6). (mean
± 95% confidence interval) (Study III)
6.4 DQCTA AND DGEMRIC – ASSOCIATION TO
ARTHROSCOPIC FINDINGS
Delayed quantitative CT arthrography (dQCTA), intravenous and
intra-articular dGEMRIC, and arthroscopic evaluation were per-
formed for 11 patients in study IV. According to visual evaluation of
cartilage lesions, CT image acquired at 5 minutes after the contrast
agent injection had the best diagnostic quality (Figure 6.4). Sig-
nificant correlations were found between dGEMRIC and dQCTA
parameters. ∆R1,IV (Figure 6.5) and ∆R1,IA/∆R1,SF correlated signifi-
cantly with dQCTA parameter C45/SF45 (C=cartilage, SF=synovial
fluid): (R = 0.72, p < 0.01) and (R = 0.70, p < 0.01), respectively.
dQCTA and dGEMRIC parameters were not significantly differ-
ent between groups with different ICRS grade. However, C45/SF45
revealed a positive trend in conjuction with increasing ICRS grade
(Figure 6.6).
An association between IA and IV dGEMRIC was found only af-
ter normalizing ∆R1,IA with ∆R1,SF: R = 0.52 between ∆R1,IA/∆R1,SF
and ∆R1,IV (p < 0.01).
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Figure 6.4: MR (A,C,E) and CT (B,D,F) images showing cartilage lesion with ICRS grade
2 (arrow). A) Anatomical MR image B) CT at 5 min after contrast agent injection, C) Pre-
contrast MR image, D) CT at 45 min after contrast agent injection, E) T1 relaxation time
map overlaid on top of a T1-weighted MR image 90 min after IV contrast agent injection
(T1,Gd) F) dQCTA map of normalized X-ray attenuation in cartilage at 45 minutes after
contrast agent injection (C45/SF45) overlaid on top of an anatomical CT image. (Contrast
of the images has been adjusted.) (Study IV)
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Figure 6.5: Significant correlation between normalized mean X-ray attenuation in cartilage
at 45 min after contrast agent injection (C45/SF45) and ∆R1,IV. Linear fit is for illustrative
purposes. The distribution of the ICRS grades was: grade 0; n=19, grade 1; n=19, grade 2;
n=19, grade 3; n=2. (Study IV)
Figure 6.6: Normalized dQCTA parameter C45/SF45 in different ICRS grade groups. In
spite of a positive trend in conjuction with increasing ICRS grade there were no significant
differences between the groups. Grades 2 and 3 were merged together due to the low number
of grade 3 lesions. (Study IV)
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7 Discussion
In this thesis, the diffusion of X-ray contrast agents was investi-
gated in intact, spontaneously healed and artificially cross-linked
cartilage in vitro. Furthermore, the clinical potential of delayed CT
arthrography was evaluated in vivo. In study I, the diffusion of stud-
ied contrast agents was found to occur faster through superficial
cartilage than through deep cartilage. In study II, CECT enabled
quantitative distinguishing of spontaneously healed cartilage and
subchondral bone from adjacent intact tissues in the equine inter-
carpal joint. In study III, the effects of increased cross-linking of
collagen on diffusion of anionic and non-ionic contrast agents were
found to be more related to the changes in tissue FCD than changes
in steric hindrance. In study IV, dGEMRIC and dQCTA (i.e. CECT in
vivo) were found to agree but not to be in line with the arthroscopic
findings.
7.1 CONTRAST AGENT DIFFUSION THROUGH
SUPERFICIAL CARTILAGE IS FASTER THAN
THROUGH DEEP CARTILAGE
In study I, the diffusion coefficients in cartilage were determined
for four contrast agents. Diffusion was allowed either through
the superficial cartilage or through deep cartilage. The smallest
molecule, iodide, displayed the highest diffusion coefficient while
the largest molecule, ioxaglate, showed the lowest diffusion coef-
ficient. This is in line with previous studies that have reported
smaller diffusion coefficients with an increasing size of the diffusing
molecule [3, 100, 101, 107, 179–182]. Two molecules with equivalent
sizes, i.e. gadopentetate and gadodiamide, exhibited no significant
(p > 0.05) differences in their diffusion coefficients even though the
molecules possess different charges.
Diffusion coefficients of gadopentate, gadodiamide and ioxaglate
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for penetration through superficial cartilage were higher than those
measured in penetration through deep cartilage. This result was ex-
pected and can be explained by the inhomogeneous composition of
cartilage: the higher water content and the lower GAG concentration
in the superficial cartilage. This is supported by previous studies
that have reported higher diffusion coefficients with increasing wa-
ter content and decreasing GAG concentration [49, 106–108, 181].
Differences in collagen network structure and orientation have been
proposed to explain the changes in diffusion coefficient of large
dextran molecules (40 kDa – 500 kDa) along the tissue depth while
the GAG concentration has been postulated to mainly hinder dif-
fusion of smaller dextran molecules (3 kDa) [100]. In contrast, a
CECT study examining the diffusion of ioxaglate (≈1.3 kDa) and
gadopentetate (≈0.5 kDa) reported that it took over 8 h to reach
the equilibrium in intact and proteoglycan depleted cartilage [79].
This suggests that collagen may also hinder the diffusion of smaller
molecules.
7.2 CECT ENABLES DETECTION OF REPAIRED
OSTEOCHONDRAL INJURIES
Spontaneously healed cartilage tissue could be quantitatively dis-
tinguished from the adjacent intact tissue in study II. The signifi-
cantly higher contrast agent diffusion coefficient in repaired tissue
may be attributable to the lower GAG content in the repair tis-
sue [49, 106–108, 181]. In addition, the abnormal structure of the
collagen network in repaired tissue may have contributed to the
higher diffusion coefficient values. The collagen fibrils in repaired
cartilage were not oriented tangentially in the superficial tissue
which can partially explain the present findings, since diffusion in
parallel to the collagen fibrils is faster than diffusion in a perpendic-
ular direction to the fibrils [101].
The concentration of the contrast agent at diffusion equilibrium
was not significantly different between repaired and intact cartilage
despite the lower GAG content in the repaired tissue. This suprising
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result may be due to the abnormal organization of the collagen
network in repaired tissue which could hinder the mobility of the
contrast agent. This is supported by a recent contrast-enhanced MRI
study where the alterations in the collagen network were reported to
have an effect on the accumulation of contrast agent in cartilage [200].
The modulus of the nonfibrillar matrix in the repaired tissue
was smaller than in the intact tissue. The GAG content is known to
be associated to the modulus of the nonfibrillar matrix [91]. Thus,
the lower GAG content detected in the repaired tissue supports
this result. The abnormal organization of the collagen network in
the repaired tissue may be responsible for the smaller modulus of
the fibrillar matrix. In particular, the lack of the superficial tangen-
tially oriented fibril layer may contribute to the inferior mechanical
properties of the repaired tissue [61, 92, 156].
The new mechanical environment of the subchondral bone un-
derneath the repaired cartilage affects the healing and remodeling
response of bone, and this may be responsible for the lower BMD
in that area [59]. The reduced values of BV/TV and BS/BV seen in
subchondral bone under repaired cartilage are typical signs of the
subchondral reaction related to an osteochondral injury [74,191,192].
7.3 CROSS-LINKING RELATED CHANGES IN FCD HAVE
GREATER EFFECT ON THE CONTRAST AGENT
DIFFUSION THAN CHANGES IN STERIC HINDRANCE
In study III, diffusion of ionic and non-ionic contrast agents was
investigated in cartilage treated with threose to increase cross-linking
of collagen. As expected in the light of the results of our earlier
study [87], partition of anionic ioxaglate was significantly lower in
the threose-treated tissue than in the reference samples. However,
there did not seem to be any difference in the partition of non-
ionic iodixanol. This suggests that the cross-links do not cause a
significant steric hindrance for these contrast agent molecules.
The elevated negative FCD in the threose-treated samples sup-
ports the finding of decreased partitioning of ioxaglate. FCD is
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traditionally assumed to be linearly related to the GAG concentra-
tion of the tissue [60, 109, 193]. However, the GAG concentration
did not exhibit a systematic change following the threose-treatment.
Pentosidine cross-links, which were significantly increased after
threose-treatment, are formed between arginine and lysine residues
in collagen [155]. This leads to the loss of positive charges of these
residues, causing the total negative FCD in cartilage to increase [62].
The cross-linking related increase in FCD challenges the traditional
interpretation of the results of dGEMRIC and CECT, since despite
the increased FCD, the GAG concentration did not change according
to these present findings and our previous study [87]. Since the
concentration of the pentosidine cross-links is reported to increase
with ageing [11], the age of a patient can affect the results achieved
by imaging techniques based on the use of charged contrast agents.
7.4 DQCTA IS IN AGREEMENT WITH DGEMRIC IN VIVO
The results obtained with dGEMRIC (intravenous and intra-articular)
and dQCTA were found to be in agreement (study IV). This was
expected, although the contrast agents (gadopentetate and ioxaglate)
differ in terms of charge and molecular mass (Table 5.3) and differ-
ences in their penetration into cartilage have been reported [15, 165].
However, in order to achieve agreement between the techniques,
dQCTA parameter and ∆R1,IA had to be normalized with the con-
trast agent concentration in synovial fluid and ∆R1,SF, respectively.
Hence, based on the present results, it is important to consider the
contrast agent concentration in synovial fluid after intra-articular
injection of contrast agent.
The results from dQCTA and dGEMRIC were not related to
arthroscopic ICRS grading. This is in line with two previous dGEM-
RIC studies in which the dGEMRIC-index did not correlate with
arthroscopic grading [132, 134]. This finding may be partially ex-
plained by the fact that while the remaining cartilage is analyzed in
dGEMRIC and dQCTA, it is the absence of cartilage which defines
the ICRS grade.
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dGEMRICIV and dGEMRICIA correlated moderately when the
∆R1,IA was normalized with ∆R1,SF. The other examined dGEMRIC
parameters showed no significant correlations. This finding may be
explained by differences in IV and IA administration techniques.
First, the volume of the contrast agent is different in IV and IA
injections. With an IV injection, it is the weight of the patient which
determines the final volume to be injected whereas with an IA
injection, the volume is the same for each patient. Second, after
intra-articular injection, the contrast agent is diluted in synovial
fluid, the volume of which is different between patients. Third, there
are differences in the pharmacokinetics of contrast agent between
IA and IV administrations, although diffusion from subchondral
bone after IV injection was found to be negligible in a recent in vivo
study [66]. This is also supported by in vitro studies [152, 165].
7.5 LIMITATIONS
There are some limitations in studies I–IV that should be addressed.
The rather low number of samples in the studies was accepted for
practical reasons. However, it was ensured that in the in vitro studies
the control and experimental samples were paired, and the test
groups included independent sample pairs.
The main limitation of study I was the rather low number of
imaging time points, partly because of long imaging time required
to achieve high resolution with an acceptable signal-to-noise ratio.
A higher number of time points, especially in the early phase of
diffusion, could have improved the accuracy of the FE model fitting.
In our MRI study of gadopentetate diffusion in bovine cartilage,
however, imaging was conducted every 6 minutes for 18 hours [152].
The diffusion data gathered in that study was analyzed in two ways:
using all the data points in the fitting and using only those data
points that corresponded to the time points of study I (1, 5, 9, 16,
18 h). A good linear correlation was found between the diffusion
coefficients analyzed in these two ways (R = 0.94). Thus, the number
of imaging time points in study I could be considered as adequate.
Dissertations in Forestry and Natural Sciences No 110 51
Katariina Nissinen: Diffusion of contrast agents in cartilage
In study II, the mechanical properties of repair cartilage were
found to be inferior when compared to those of intact cartilage.
When testing the samples with creep indentation, it was challenging
to achieve good contact between cartilage and the indenter. There-
fore, the first compressive step was considered a prestep in the
simulations of creep behaviour of both repair and intact cartilage.
Another limitation of study II was that the sample-specific material
properties (depth-dependent collagen orientation, collagen concen-
tration and PG concentration) of cartilage were not implemented
in the FE model. Implementation of the sample-specific properties
could have affected the simulated results, but would have made the
modeling more complex.
In study III, the effects of age-related changes in the collagen
network on the diffusion of the contrast agent were investigated. The
cross-links were created chemically using threose but these may not
perfectly mimic the changes in collagen network occurring during
ageing. Further, cartilage undergoes also other changes with age, e.g.
surface fibrillation, decreased size of PG aggregates, and decreased
water content [24,111]. However, incubation in threose did represent
a feasible way to increase pentosidine cross-links in order to modify
the structure of the collagen network in a way typical of natural
ageing [11].
Due to the complicated experimental set-up carried out with
clinical patients in study IV, certain limitations had to be accepted.
First, the time delay between contrast agent injection and imaging
was different in dGEMRIC and dQCTA for practical reasons. The
selection of the time points was based on the literature [43, 86, 176],
and the contrast agents for dGEMRICIA and dQCTA were chosen
to be injected at the same time for ethical reasons. Second, in the
first patient, the IA injection was given to the suprapatellar recess,
which is the most common site for intra-articular injections [54, 78].
Unfortunately, this resulted in an uneven distribution of contrast
agent in the joint cavity. For the remainder of the patients, the con-
trast agent was injected directly into the joint space between femur
and tibia. Third, although there were differences in the segment-
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ing procedures of dGEMRIC and dQCTA images, the agreement
could be confirmed visually. It was possible to use semi-automated
segmentation in dQCTA analysis due to higher contrast between
cartilage and adjacent tissues. In addition, two-dimensional (2D)
ROI was segmented in dGEMRIC in contrast to 3D ROI in dQCTA
as acquisition of only single-slice in dGEMRIC enabled reasonable
imaging times.
7.6 DQCTA – CURRENT STATUS
dQCTA is already a clinically available imaging technique. As
a result of the advances in CT technology, clinical microCT with
a 41 µm isotropic voxel size which allows imaging of peripheral
joints is already on the market (XtremeCT, SCANCO Medical AG,
Brüttisellen, Switzerland) [154]. Such a high level of resolution will
also allow simultaneous, reliable, and quantitative evaluation of the
bone microstructure [73].
HexabrixTM (ioxaglate) is a widely used X-ray contrast agent
and it is appropriate for dQCTA. In study IV, the concentration of
HexabrixTM was 105 mM (diluted to 25% of full strength HexabrixTM).
However, full strength HexabrixTM injections have been applied and
these would enable better delineation of cartilage in the arthro-
graphic images. Full strength HexabrixTM with osmolality of 600
mOsm/kg [46] is hyperosmolalic when compared to the synovial
fluid with osmolality of approximately 300-400 mOsm/kg [19, 63].
Hyperosmolalic environment causes softening of the cartilage due
to decreased osmotic pressure [48,90]. Softening of the cartilage may
increase the risk of mechanical damage and increased cell death if
cartilage is subjected to loading after injection of hyperosmolaric
contrast agent [186]. This is important to be borne in mind since
usually the joint needs to be exercised after injection to ensure an
even distribution of contrast agent. However, in clinical practice
intra-articular injection of full strength HexabrixTM may be consid-
ered safe if the joint is not heavily loaded and as contrast agent
dilutes significantly when mixing with synovial fluid.
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Since each patient has a different amount of synovial fluid, the
contrast agent concentration in the joint capsule varies among pa-
tients. This should not affect the interpretation of dQCTA images
since contrast agent concentration has been reported not to affect the
partitioning in cartilage in vitro [162]. However, in order to ensure
adequate contrast, a high enough concentration and volume needs to
be injected. This is to assure that the contrast agent is not excessively
diluted in synovial fluid. A volume of 20 ml was used in study
IV (concentration: 105 mM) and in an earlier study (concentration:
210 mM) [86]. In those cases where the knee is very swollen, the
synovial fluid may need to be aspirated before injection of contrast
agent [54].
Cationic contrast agents have shown potential for more sensitive
detection of changes in cartilage FCD. Cationic contrast agents have
been reported to penetrate to higher concentrations in cartilage than
anionic contrast agents which eases the segmentation of cartilage
[14, 15, 75, 170]. Despite the positive charge strongly attracted by
cartilage, the contrast agent has been reported to be washed out of
the rabbit joint in vivo and to be safe according to histopathologic
examination of cartilage after imaging experiments [170].
It has been suggested that three acquisitions should be included
in the dQCTA protocol: non-contrast, arthrographic and delayed [86].
In study IV, only arthrographic and delayed images were acquired
to minimize the radiation dose. According to the radiologist, the
arthrographic image had the best diagnostic quality for detection
of cartilage lesions. However, in order to be able to evaluate the
condition of the cartilage surrounding the lesion, it was found nec-
essary to use the delayed image. Due to rather slow diffusion of
contrast agent into cartilage, only a very small amount of contrast
agent can be expected to be present in cartilage at the moment of
acquisition of the arthrographic image. Thus, the necessity of the
non-contrast image can be questioned. The subtraction image is
achieved by subtracting the arthrographic image from the delayed
image, and then the amount of contrast agent diffused into cartilage
between these two time points (5 min and 45 min in study IV) can
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be calculated. This may serve as an adequate indicator of the state
of the cartilage.
The effective radiation dose received by a patient during one
scan with the XtremeCT scanner mentioned earlier is less than 5 µSv
based on the information given by the manufacturer [154]. Thus, the
total dose of two sequential scans would correspond approximately
one day’s exposure to the background radiation in Finland.
7.7 DQCTA – FUTURE
dQCTA is a promising clinical method for quantitative diagnosis of
cartilage injuries and degeneration. However, further studies with
larger populations including healthy participants and patients with
OA are needed to optimize the technique and to fully characterize its
potential. For example, a study with patients referred to total knee
replacements would allow biochemical and histological evaluation
of cartilage as a reference to the results of dQCTA.
From the modeling perspective, development of a sophisticated
diffusion model would be important. With the aid of the model, it
would be possible to determine the individual contribution of dif-
ferent constituents of cartilage to the diffusion process. The model
should take into account the contribution of electrostatic interac-
tions of contrast agent molecules with proteoglycans. Structural
orientation of the collagen network and the size of the diffusing
molecule should also be included into the model. Then, combina-
tion of dQCTA and modeling would enable compositional imaging
which would help in the early diagnosis of OA and evaluation of
cartilage repair.
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8 Summary and conclusions
In this thesis, factors affecting diffusion and distribution of X-ray
contrast agents in articular cartilage were investigated. Finally, CECT
was applied in vivo together with dGEMRIC, and their association
was compared to the arthroscopic evaluation of the knee. The main
findings of this thesis are summarized as follows:
1. The tissue-averaged axial diffusion coefficients of four contrast
agents in cartilage could be determined. Diffusion through
the articular surface was faster than through deep cartilage.
This appeared to reflect the differences in composition along
the cartilage depth: higher water content and lower GAG
concentration in superficial than in deep cartilage.
2. MicroCECT was able to quantitatively distinguish the sponta-
neously healed repair site from adjacent intact tissue.
3. Cross-linking induced changes in cartilage fixed charge density
had a greater effect on diffusion of anionic contrast agent
compared to the changes in steric hindrance.
4. dQCTA normalized with the contrast agent concentration in
synovial fluid achieved the best agreement with dGEMRIC (in-
travenous and intra-articular) at 45 minutes after intra-articular
injection of X-ray contrast agent. However, neither of the tech-
niques revealed any correlation to arthroscopic findings. This
is probably because the remaining cartilage is analyzed in
dQCTA and dGEMRIC, while it is the absence of cartilage
which defines the ICRS grade.
5. Since normalizing with the contrast agent concentration in
synovial fluid was found to be of great importance, it is pro-
posed to be taken into account in future clinical application of
dQCTA.
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dQCTA is a promising clinical method for quantitative diagnosis
of cartilage injuries and degeneration. The further development of
dQCTA would require clinical studies with healthy and OA patients,
and patients referred to total knee replacement which would per-
mit the collection of tissue samples for reference measurements. In
addition, the development of a composition-based diffusion model,
which would take into account the individual contribution of differ-
ent constituents of cartilage to the contrast agent diffusion, would
enable compositional imaging when combined with dQCTA. This
would help in the early diagnosis of OA and in the evaluation of
cartilage repair.
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Katariina Nissinen
Diffusion of X-ray Contrast Agents 
in Intact and Repaired Articular 
Cartilage
Early degenerative changes 
of articular cartilage are not 
diagnosed sensitively enough with 
conventional imaging techniques. 
The diagnostic potential of contrast 
enhanced computed tomography 
(CECT) was investigated in this 
thesis in vitro and in vivo. Imaging 
the diffusion dynamics of the 
contrast agent in articular cartilage 
was found to provide valuable 
information about the integrity and 
composition of cartilage matrix. 
Based on the present findings, it 
seems that delayed quantitative CT 
arthrography (dQCTA i.e. CECT in 
vivo) is a potentially useful method 
in the quantitative diagnostic 
imaging of articular cartilage.
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